Testing amino acid needs in TPN-fed premature newborns
This study looks at how much phenylalanine, methionine, and histidine premature babies need while they are fed only through a vein (TPN). The goal is to make sure the nutrient amounts in TPN support healthy growth safely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby must be born at 28 weeks or later
- Your baby must be 28 days old or younger when the study starts
- Your baby must be getting at least 90% of calories and protein from TPN (IV nutrition)
- Your baby must be medically stable with normal blood tests and no fever or infection
- If your baby had surgery, they must be at least 3 days past surgery
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks how much of certain proteins (amino acids) premature babies need when they get all their nutrition through an IV. It aims to make sure babies get the right amounts to grow well.
This trial tests an AI tool to help manage total parenteral nutrition (IV feeding) for newborns in the neonatal ICU who need daily lab tests. It aims to make nutrition safer and more personalized.
This study looks at how premature babies grow and handle feeding when they get breast milk or donor milk. It aims to find the best ways to feed preterm infants to help them gain weight and stay healthy.
This study compares two ways of starting tiny feedings in very premature babies. The goal is to see if a shorter or longer period of very small feedings leads to better growth and fewer feeding problems. If you are okay with your baby receiving donor breast milk when needed, this trial may be a good fit.
This study looks at whether giving protein continuously or all at once is better for children in intensive care. The goal is to find the most effective way to support recovery.
This trial tests whether giving an omega-3 fat medicine through an IV (along with standard care) improves breathing and blood-flow problems in newborns with congenital diaphragmatic hernia and persistent pulmonary hypertension. It may help reduce strain on the lungs and heart by targeting inflammation and blood-vessel changes.
Hear when a new Stable Neonates trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.